Skip to main content

Advertisement

Table 2 Identified patient access schemes in Australia

From: Patient access schemes in Asia-pacific markets: current experience and future potential

Technology Indication Company Payer Type Source
Cancer (n = 29)
Dasatinib CML Bristol-Myers Squibb Australia Pty Ltd PBS Outcome-based Medicare Australia [14]
Nilotinib CML Novartis Pharmaceuticals Australia Pty Ltd PBS Outcome-based Medicare Australia [14]
Imatinib GIST, adjuvant Novartis Pharmaceuticals Australia Pty Ltd PBS Outcome-based Medicare Australia [14]
Imatinib GIST, metastatic Novartis Pharmaceuticals Australia Pty Ltd PBS Outcome-based Medicare Australia [14]
Lapatinib Late stage metastatic breast cancer GlaxoSmithKline Australia Pty Ltd PBS Outcome-based Medicare Australia [14]
Imatinib Rare cancers (eg dermatofibrosarcoma protuberans, chronic eosinophilic leukemia) Novartis Pharmaceuticals Australia Pty Ltd PBS Outcome-based Medicare Australia [14]
Pazopanib RCC GlaxoSmithKline Australia Pty Ltd PBS Financially-based; Outcome-based Public Summary Document [18]
Bevacizumab Metastatic colorectal cancerr Roche Products Pty Ltd PBS Financially-based; Outcome-based Public Summary Document [18]
Sorafenib Advanced hepatocellular carcinoma Bayer Australia Ltd PBS Financially-based; Outcome-based Public Summary Document [18]
PET Staging of newly diagnosed NSCLC, esophageal cancer, cancer of gastro-esophageal junction, head and neck cancer, suspected residual/metastatic/recurrent colorectal cancer, melanoma, head and neck cancer, ovarian cancer Not specified MBS Evidence generation Stafinski et al. 2010 [15]
Exemestane Oestrogen-receptor positive advanced breast cancer in post-menopausal women Pfizer Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Imiquimod Superficial basal cell carcinoma 3 M Pharmaceuticals Pty Ltd PBS Financially-based Public Summary Document [18]
Letrozole Advanced breast cancer in postmenopausal women Novartis Pharmaceuticals Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Docetaxel SCCHN Sanofi-Aventis Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Sunitinib RCC Pfizer Australia Pty Ltd PBS Financially-based PBS Schedule [16], Public Summary Document [18]
Cetuximab K-RAS wild mCRC Merck Serono Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Vemurafenib Untreated unresectable stage IIIC or stage IV melanoma Roche Products Pty Ltd PBS Financially-based Public Summary Document [18]
Imatinib ALL Novartis Pharmaceuticals Australia Pty Ltd PBS Financially-based; Outcome-based PBPA Relativity Sheets [17], Public Summary Document [18], Medicare Australia [14]
Dasatinib ALL Bristol-Myers Squibb Australia Pty Ltd PBS Financially-based; Outcome-based PBPA Relativity Sheets [17], Public Summary Document [18], Medicare Australia [14]
Azacitidine CML Celgene Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Azacitidine AML Celgene Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Azacitidine Myelodysplastic syndrome Celgene Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Imatinib CML Novartis Pharmaceuticals Australia Pty Ltd PBS Financially-based; Outcome-based PBPA Relativity Sheets [17], Medicare Australia [14]
Trastuzumab HER2+ early breast cancer Roche Products Pty Ltd PBS Financially-based; Outcome-based PBPA Relativity Sheets [17], Medicare Australia [14]
Sunitinib GIST Pfizer Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Lenalidomide Myelodysplastic syndrome Celgene Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Lenalidomide Multiple myeloma Celgene Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Bortezomib Multiple myeloma Janssen-Cilag Pty Ltd PBS Financially-based, Outcome-based PBS Schedule [16], PBPA Relativity Sheets [17], Public Summary Document [18], Medicare Australia [14]
Erlotinib Non-small cell lung cancer Roche Products Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Inflammatory Conditions (n = 28)
Adalimumab Ankylosing spondylitis AbbVie Pty Ltd PBS Outcome-based Medicare Australia [14]
Etanercept Ankylosing spondylitis Pfizer Australia Pty Ltd PBS Outcome-based Medicare Australia [14]
Golimumab Ankylosing spondylitis Janssen-Cilag Pty Ltd PBS Outcome-based Medicare Australia [14]
Infliximab Ankylosing spondylitis Janssen-Cilag Pty Ltd PBS Outcome-based Medicare Australia [14]
Adalimumab Crohn’s disease AbbVie Pty Ltd PBS Outcome-based Medicare Australia [14]
Infliximab Complex refractory fistulising Crohn’s disease Janssen-Cilag Pty Ltd PBS Outcome-based Medicare Australia [14]
Adalimumab Juvenile arthritis AbbVie Pty Ltd PBS Outcome-based Medicare Australia [14]
Etanercept Juvenile arthritis Pfizer Australia Pty Ltd PBS Outcome-based Medicare Australia [14]
Adalimumab Psoriatic arthritis AbbVie Pty Ltd PBS Outcome-based Medicare Australia [14]
Golimumab Psoriatic arthritis Janssen-Cilag Pty Ltd( PBS Outcome-based Medicare Australia [14]
Infliximab Psoriatic arthritis Janssen-Cilag Pty Ltd PBS Outcome-based Medicare Australia [14]
Pimecrolimus Atopic dermatitis who are over 18 years of age Novartis Pharmaceuticals Australia PBS Financially-based Public Summary Document [18]
Infliximab Crohn’s disease Janssen-Cilag Pty Ltd PBS Financially-based; Outcome-based PBPA Relativity Sheets [17], Medicare Australia [14]
Adalimumab Complex refractory fistulising Crohn’s disease AbbVie Pty Ltd PBS Financially-based; Outcome-based PBPA Relativity Sheets [17], Medicare Australia [14]
Tocilizumab Juvenile arthritis Roche Products Pty Ltd PBS Financially-based; Outcome-based PBPA Relativity Sheets [17], Medicare Australia [14]
Abatacept RA Novartis Pharmaceuticals Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Infliximab RA Janssen-Cilag Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Lu et al. 2007 [33], Pugatch et al. 2010 [21], Medicare Australia [14]
Rituximab RA Roche Products Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Lu et al. 2007 [33], Pugatch et al. 2010 [21], Medicare Australia [14]
Tocilizumab RA Roche Products Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Certolizumab Pegol RA UCB Australia Proprietary Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Adalimumab RA AbbVie Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Lu et al. 2007 [33], Pugatch et al. 2010 [21], Medicare Australia [14]
Golimumab RA Janssen-Cilag Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Etanercept RA Pfizer Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Lu et al. 2007 [33], Pugatch et al. 2010 [21], Medicare Australia [14]
Adalimumab Severe chronic plaque psoriasis AbbVie Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Lu et al. 2007 [33], Pugatch et al. 2010 [21], Medicare Australia [14]
Etanercept Severe chronic plaque psoriasis Pfizer Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Infliximab Severe chronic plaque psoriasis Janssen-Cilag Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Ustekinumab Severe chronic plaque psoriasis Janssen-Cilag Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Etanercept Severe chronic plaque psoriasis under 18 Pfizer Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Infectious Diseases (n = 7)
Abacavir HIV infection ViiV Healthcare Pty Ltd PBS Financially-based Robertson et al. 2009 [19], Adamski et al. 2010 [20]
Tipranavir HIV infection Boehringer Ingelheim Pty Ltd PBS Financially-based PBS Schedule [16], Public Summary Document [18]
Entecavir Chronic hepatitis B in adults 16 years and older with evidence of active liver inflammation Bristol-Myers Squibb Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Boceprevir Chronic genotype 1 hepatitis C infection Merck Sharp & Dohme (Australia) Pty Ltd PBS Financially-based Public Summary Document [18]
Telaprevir Chronic genotype 1 hepatitis C Janssen-Cilag Pty Ltd PBS Financially-based Public Summary Document [18]
Posaconazole Invasive fungal infections, not responsive to or intolerant of, alternative therapy Schering-Plough Pty Ltd PBS Financially-based Public Summary Document [18]
Posaconazole Prophylaxis of invasive fungal infections among high risk patients Schering-Plough Pty Ltd PBS Financially-based Public Summary Document [18]
Pulmonary Hypertension (n = 7)
Sildenafil PPH or PAH Pfizer Australia Pty Ltd PBS Outcome-based PBS Schedule [16], Medicare Australia [14]
Tadalafil PPH or PAH Eli Lilly Australia Pty Ltd PBS Outcome-based PBS Schedule [16], Medicare Australia [14]
Treprostinil Sodium PPH or PAH Orphan Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Ambrisentan PPH or PAH GlaxoSmithKline Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Bosentan PPH or PAH Actelion Pharmaceuticals Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], PBPA Relativity Sheets [17], Public Summary Document [18], Medicare Australia [14]
Epoprostenol PPH or PAH GlaxoSmithKline Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], PBPA Relativity Sheets [17], Public Summary Document [18], Medicare Australia [14]
Iloprost trometamol PPH or PAH Bayer Australia Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Other (n = 27)
Modafinil Narcolepsy bioCSL (Australia) Pty Ltd PBS Outcome-based Medicare Australia [14]
Verteporfin Age-related macular degeneration Novartis Pharmaceuticals Australia Pty Ltd PBS Outcome-based Medicare Australia [14]
Deep brain stimulation Patients with Parkinson's disease no longer responsive to drug therapy Not specified MBS Evidence generation Stafinski et al. 2010 [15]
EVAR Abdominal aortic aneurysm Not specified MBS Evidence generation Stafinski et al. 2010 [15]
Dabigatran Prevention of stroke or systemic embolism in patients with non-valvular atrial fibrillation Boehringer Ingelheim Pty Ltd PBS Financially-based Public Summary Document [18]
Atomoxetine Hydrochloride ADHD diagnosed between the ages of 6 and 18 years Eli Lilly Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Fingolimod RRMS Novartis Pharmaceuticals Australia Pty Ltd PBS Financially-based; Outcome-based Public Summary Document [18]
Cinacalcet Hydrochloride End stage renal disease receiving dialysis who have uncontrolled secondary hyperparathyroidism Amgen Australia Pty Ltd PBS Financially-based PBS Schedule [16], Public Summary Document [18]
Clostridium botulinum type A toxin-haemagglutinin complex Severe spasticity of the upper limb in adults following a stroke, as an adjunct to physical therapy Ipsen Pty Ltd PBS Financially-based Public Summary Document [18]
Fentanyl citrate Fentanyl lozenges for the treatment of breakthrough pain Orphan Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Natalizumab RRMS Biogen Idec Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Paliperidone Schizophrenia Janssen-Cilag Pty Ltd PBS Financially-based Public Summary Document [18]
Botulinum toxin type a purified neurotoxin complex Moderate to severe spasticity of the upper limb in adults following a stroke as an adjunct to physical therapy Allergan Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Tenofovir Disoproxil Fumarate Treatment of chronic hepatitis B Gilead Sciences Pty Ltd PBS Financially-based Public Summary Document [18]
Pramipexole hydrochloride Idiopathic Parkinson disease Boehringer Ingelheim Pty Ltd PBS Financially-based Public Summary Document [18]
Tobramycin Pseudomonas aeruginosa respiratory infection in a patient with Cystic Fibrosis Novartis Pharmaceuticals Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Ticagrelor ACS, MI, or unstable angina AstraZeneca Pty Ltd PBS Financially-based Public Summary Document [18]
Pregabalin Neuropathic pain Pfizer Australia Pty Ltd PBS Financially-based Public Summary Document [18]
Rivaroxaban Acute symptomatic DVT Bayer Australia Ltd PBS Financially-based Public Summary Document [18]
Aztreonam Pseudomonas aeruginosa infection in patients with cystic fibrosis Gilead Sciences Pty Ltd PBS Financially-based Public Summary Document [18]
Crinone (progesterone gel) Supplement progesterone in women who have luteal phase defect Merck Serono PBS Financially-based Robertson et al. 2009 [19], Adamski et al. 2010 [20]
Deferasirox (Exjade) Chronic iron overload in patients with disorders of erythropoiesis Novartis PBS Financially-based Robertson et al. 2009 [19], Adamski et al. 2010 [20]
Omalizumab Uncontrolled severe allergic asthma Novartis Pharmaceuticals Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Aflibercept Age-related macular degeneration Bayer Australia Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
Ranibizumab Age-related macular degeneration Novartis Pharmaceuticals Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], PBPA Relativity Sheets [17], Public Summary Document [18], Medicare Australia [14]
Eltrombopag Severe chronic immune idiopathic thrombocytopenic purpura GlaxoSmithKline Australia Pty Ltd PBS Financially-based; Outcome-based PBPA Relativity Sheets [17], Medicare Australia [14]
Romiplostim Severe chronic immune idiopathic thrombocytopenic purpura Amgen Australia Pty Ltd PBS Financially-based; Outcome-based PBS Schedule [16], Medicare Australia [14]
  1. ACS = Acute Coronary Syndromes; ALL = Acute Lymphoblastic Leukemia; AML = Acute Myeloid Leukemia; CML = Chronic Myeloid Leukemia; DVT = Deep Vein Thrombosis; EVAR = endovascular aneurysm repair; GIST = Gastrointestinal Stromal Tumor; MBS = Medicare Benefits Schedule; mCRC = Metastatic Colorectal Cancer; MI = Myocardial Infarction; PAH = Pulmonary Arterial Hypertension; PBS = Pharmaceutical Benefits Scheme; PPH = Primary Pulmonary Hypertension; RA = Rheumatoid Arthritis; RCC = Renal Cell Carcinoma; RRMS = Relapsing-Remitting Multiple Sclerosis; SCCHN = Squamous Cell Carcinoma of the Head and Neck.